Profile
Mette Thorn worked as a Senior Vice President-Preclinical Development at Expres2ion Biotech Holding AB from 2021 to 2023.
She received a graduate and doctorate degree from the Technical University of Denmark.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/09/2022 | 860 ( 0.00% ) | 198 $ | 30/03/2024 |
Former positions of Mette Thorn
| Companies | Position | End |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Chief Tech/Sci/R&D Officer | 28/09/2023 |
Training of Mette Thorn
| Technical University of Denmark | Doctorate Degree |
Experiences
Positions held
Connections
7
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
- Stock Market
- Insiders
- Mette Thorn
